18-671648-A-T

Position:

• chr18-671648-A-T

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_Strong BA1

The NM_017512.7(ENOSF1):​c.*2657T>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.375 in 602,476 control chromosomes in the GnomAD database, including 45,874 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

• Frequency:
  • Genomes: 𝑓 0.40 (13418 hom., cov: 33)
  • Exomes 𝑓: 0.37 (32456 hom.)
• Consequence: ENOSF1 NM_017512.7 3_prime_UTR
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: -0.380

Genes affected

ENOSF1 (HGNC:30365): (enolase superfamily member 1) This gene can encode a mitochondrial enzyme that is thought to convert L-fuconate to 2-keto-3-deoxy-L-fuconate. This locus was originally identified as the source of antisense RNAs of the adjacent thymidylate synthase gene. Splice variants at this locus may contain an alternate 3' exon that is complementary to the 3'UTR and terminal intron of the thymidylate synthase (TS) RNA and may downregulate TS expression. [provided by RefSeq, Aug 2017]

TYMS (HGNC:12441): (thymidylate synthetase) Thymidylate synthase catalyzes the methylation of deoxyuridylate to deoxythymidylate using, 10-methylenetetrahydrofolate (methylene-THF) as a cofactor. This function maintains the dTMP (thymidine-5-prime monophosphate) pool critical for DNA replication and repair. The enzyme has been of interest as a target for cancer chemotherapeutic agents. It is considered to be the primary site of action for 5-fluorouracil, 5-fluoro-2-prime-deoxyuridine, and some folate analogs. Expression of this gene and that of a naturally occurring antisense transcript, mitochondrial enolase superfamily member 1 (GeneID:55556), vary inversely when cell-growth progresses from late-log to plateau phase. Polymorphisms in this gene may be associated with etiology of neoplasia, including breast cancer, and response to chemotherapy. [provided by RefSeq, Aug 2017]

ENOSF1 (HGNC:):

ACMG classification

Verdict is Benign. Variant got -12 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.84).
• BA1: GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.666 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	Protein	UniProt
ENOSF1	NM_017512.7	c.*2657T>A		3_prime_UTR_variant	16/16	ENST00000647584.2	NP_059982.2
TYMS	NM_001071.4	c.804+197A>T		intron_variant		ENST00000323274.15	NP_001062.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Protein	Appris	UniProt
ENOSF1	ENST00000647584	c.*2657T>A		3_prime_UTR_variant	16/16		NM_017512.7	ENSP00000497230.2
TYMS	ENST00000323274.15	c.804+197A>T		intron_variant		1	NM_001071.4	ENSP00000315644.10

Frequencies

GnomAD3 genomes AF: 0.404 AC: 61401 AN: 151898 Hom.: 13403 Cov.: 33

Gnomad AFR AF: 0.553

Gnomad AMI AF: 0.165

Gnomad AMR AF: 0.338

Gnomad ASJ AF: 0.396

Gnomad EAS AF: 0.685

Gnomad SAS AF: 0.452

Gnomad FIN AF: 0.324

Gnomad MID AF: 0.481

Gnomad NFE AF: 0.320

Gnomad OTH AF: 0.402

GnomAD4 exome AF: 0.366 AC: 164724 AN: 450460 Hom.: 32456 Cov.: 3 AF XY: 0.368 AC XY: 89169 AN XY: 241996

Gnomad4 AFR exome AF: 0.557

Gnomad4 AMR exome AF: 0.317

Gnomad4 ASJ exome AF: 0.383

Gnomad4 EAS exome AF: 0.660

Gnomad4 SAS exome AF: 0.441

Gnomad4 FIN exome AF: 0.319

Gnomad4 NFE exome AF: 0.319

Gnomad4 OTH exome AF: 0.382

GnomAD4 genome AF: 0.404 AC: 61447 AN: 152016 Hom.: 13418 Cov.: 33 AF XY: 0.409 AC XY: 30368 AN XY: 74310

Gnomad4 AFR AF: 0.553

Gnomad4 AMR AF: 0.337

Gnomad4 ASJ AF: 0.396

Gnomad4 EAS AF: 0.685

Gnomad4 SAS AF: 0.449

Gnomad4 FIN AF: 0.324

Gnomad4 NFE AF: 0.320

Gnomad4 OTH AF: 0.405

Alfa AF: 0.356 Hom.: 1261

Bravo AF: 0.412

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.84
CADD	Benign	0.90
DANN	Benign	0.39

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs2853537; hg19: chr18-671648; COSMIC: COSV51895977; COSMIC: COSV51895977;